Genetic and epigenetic alterations of the LKB1 gene and their associations with mutations in TP53 and EGFR pathway genes in Korean non-small cell lung cancers.

[1]  T. Mäkelä,et al.  The tumor suppressor kinase LKB1: lessons from mouse models. , 2011, Journal of molecular cell biology.

[2]  Leah E. Mechanic,et al.  Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer , 2011, Oncogene.

[3]  J. Tamburini,et al.  LKB1/AMPK/mTOR signaling pathway in hematological malignancies: From metabolism to cancer cell biology , 2011, Cell cycle.

[4]  C. Elmets,et al.  Liver kinase B1 (LKB1) in the pathogenesis of epithelial cancers. , 2011, Cancer letters.

[5]  M. Peppelenbosch,et al.  The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling , 2011, Oncogene.

[6]  T. Mäkelä,et al.  Molecular mechanisms of tumor suppression by LKB1 , 2011, FEBS letters.

[7]  H. Ji,et al.  LKB1 in lung cancerigenesis: a serine/threonine kinase as tumor suppressor , 2011, Protein & Cell.

[8]  H. Jeon,et al.  Somatic Mutations in Epidermal Growth Factor Receptor Signaling Pathway Genes in Non-small Cell Lung Cancers , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[9]  Chang Ho Kim,et al.  TP53 Mutations in Korean Patients with Non-small Cell Lung Cancer , 2010, Journal of Korean medical science.

[10]  J. Park,et al.  LKB1 mutations are extremely rare in Korean non-small cell lung cancers. , 2010, Cancer genetics and cytogenetics.

[11]  Jun Yokota,et al.  A gene‐alteration profile of human lung cancer cell lines , 2009, Human mutation.

[12]  Hojoong Kim,et al.  Lung cancer patients who are asymptomatic at diagnosis show favorable prognosis: a korean Lung Cancer Registry Study. , 2009, Lung cancer.

[13]  M. Sanchez-Cespedes,et al.  BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer. , 2009, Carcinogenesis.

[14]  Brian H. Dunford-Shore,et al.  Somatic mutations affect key pathways in lung adenocarcinoma , 2008, Nature.

[15]  D. Hayes,et al.  Role of LKB1 in lung cancer development , 2008, British Journal of Cancer.

[16]  M. Meyerson,et al.  Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients , 2008, British Journal of Cancer.

[17]  J. Herman,et al.  Epigenetic alteration of Wnt pathway antagonists in progressive glandular neoplasia of the lung. , 2008, Carcinogenesis.

[18]  M. Moasser,et al.  The epidermal growth factor receptor family: Biology driving targeted therapeutics , 2008, Cellular and Molecular Life Sciences.

[19]  M. Sanchez-Cespedes.  A role for LKB1 gene in human cancer beyond the Peutz–Jeghers syndrome , 2007, Oncogene.

[20]  Y. Yatabe,et al.  LKB1 gene mutations in Japanese lung cancer patients , 2007, Cancer science.

[21]  C. H. Kim,et al.  Aberrant DNA methylation profiles of non-small cell lung cancers in a korean population , 2007 .

[22]  J. Minna,et al.  Prevalence and specificity of LKB1 genetic alterations in lung cancers , 2007, Oncogene.

[23]  D. Neil Hayes,et al.  LKB1 modulates lung cancer differentiation and metastasis , 2007, Nature.

[24]  M. Taketo,et al.  Accelerated onsets of gastric hamartomas and hepatic adenomas/carcinomas in Lkb1+/−p53−/− compound mutant mice , 2006, Oncogene.

[25]  A. Gazdar,et al.  Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers , 2006, International journal of cancer.

[26]  C. Amos,et al.  Mutation of Lkb1 and p53 genes exert a cooperative effect on tumorigenesis. , 2005, Cancer research.

[27]  M. Paz,et al.  Distinctive gene expression of human lung adenocarcinomas carrying LKB1 mutations , 2004, Oncogene.

[28]  J. Minna,et al.  Molecular genetics of lung cancer. , 2003, Seminars in oncology.

[29]  R. Houlston,et al.  Further observations on LKB1/STK11 status and cancer risk in Peutz–Jeghers syndrome , 2003, British Journal of Cancer.

[30]  J. Minna,et al.  Smoke exposure, histologic type and geography‐related differences in the methylation profiles of non‐small cell lung cancer , 2003, International journal of cancer.

[31]  David Sidransky,et al.  Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. , 2002, Cancer research.

[32]  John K. Wiencke,et al.  p16INK4a and Histology-specific Methylation of CpG Islands by Exposure to Tobacco Smoke in Non-Small Cell Lung Cancer , 2001 .

[33]  Y. Yarden,et al.  Untangling the ErbB signalling network , 2001, Nature Reviews Molecular Cell Biology.

[34]  A J Krush,et al.  Increased risk of cancer in the Peutz-Jeghers syndrome. , 1987, The New England journal of medicine.